Gene · 865
Papers3,690
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,690
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo. | Leukemia | 2023 | 37464068 | PubTator, text mining | PubMed |
| Single cell RNA sequencing unravels mechanisms underlying senescence-like phenotypes of alveolar macrophages. | iScience | 2023 | 37456831 | PubTator, text mining | PubMed |
| Paper-based biosensors as point-of-care diagnostic devices for the detection of cancers: a review of innovative techniques and clinical applications. | Front Oncol | 2023 | 37456253 | PubTator, text mining | PubMed |
| The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers. | Hum Genomics | 2023 | 37454130 | PubTator, text mining | PubMed |
| The Crucial Findings Derived from the Special Issue "Inside Cancer Genomics: From Structure to Therapy". | Cancers (Basel) | 2023 | 37444598 | PubTator, text mining | PubMed |
| Optimized Modeling of Metastatic Triple-Negative Invasive Lobular Breast Carcinoma. | Cancers (Basel) | 2023 | 37444409 | PubTator, text mining | PubMed |
| Impact of Next-Generation Sequencing in Diagnosis, Prognosis and Therapeutic Management of Acute Myeloid Leukemia/Myelodysplastic Neoplasms. | Cancers (Basel) | 2023 | 37444390 | PubTator, text mining | PubMed |
| Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights. | Cells | 2023 | 37443737 | PubTator, text mining | PubMed |
| Extracellular matrix-derived peptide stimulates the generation of endocrine progenitors and islet organoids from iPSCs. | J Tissue Eng | 2023 | 37435573 | PubTator, text mining | PubMed |
| The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients. | Front Med (Lausanne) | 2023 | 37435533 | PubTator, text mining | PubMed |
| Donor Cell Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation. | J Hematol | 2023 | 37435412 | PubTator, text mining | PubMed |
| TP53-Mutated Myelodysplasia and Acute Myeloid Leukemia. | Mediterr J Hematol Infect Dis | 2023 | 37435040 | PubTator, text mining | PubMed |
| Novel RUNX1 Variation in B-cell Acute Lymphoblastic Leukemia. | Mediterr J Hematol Infect Dis | 2023 | 37435033 | PubTator, text mining | PubMed |
| CircRNA: a rising star in leukemia. | PeerJ | 2023 | 37431465 | PubTator, text mining | PubMed |
| Novel circular RNAs of the apoptosis-related BAX and BCL2L12 genes identified in a chronic lymphocytic leukemia cell line using nanopore sequencing. | FEBS Open Bio | 2023 | 37424436 | PubTator, text mining | PubMed |
| Structural insights into RNA bridging between HIV-1 Vif and antiviral factor APOBEC3G. | Nat Commun | 2023 | 37419875 | Swiss-Prot, curated | PubMed |
| Host cell restriction factors of equine infectious anemia virus. | Virol Sin | 2023 | 37419416 | PubTator, text mining | PubMed |
| The Role of Regulatory T Cells in the Onset and Progression of Primary Sjögren's Syndrome. | Cells | 2023 | 37408193 | PubTator, text mining | PubMed |
| RUNX3 inactivates oncogenic MYC through disruption of MYC/MAX complex and subsequent recruitment of GSK3β-FBXW7 cascade. | Commun Biol | 2023 | 37400551 | PubTator, text mining | PubMed |
| Proposal of a new genomic framework for categorization of pediatric acute myeloid leukemia associated with prognosis. | Res Sq | 2023 | 37398194 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/865/papers?page=13